Equity Overview
Price & Market Data
Price: $1.40
Daily Change: $0.00 / 0.00%
Daily Range: $1.40 - $1.45
Market Cap: $156,352,128
Daily Volume: 1,469
Performance Metrics
1 Week: 14.75%
1 Month: 44.21%
3 Months: 40.00%
6 Months: 30.84%
1 Year: 64.71%
YTD: 46.78%
Company Details
Employees: 23
Sector: Health technology
Industry: Biotechnology
Country: Canada
Details
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.